Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA

by Del Re, Marzia, Tiseo, Marcello, Bordi, Paola, D'Incecco, Armida, Camerini, Andrea, Petrini, Iacopo, Lucchesi, Maurizio, Inno, Alessandro, Spada, Daniele, Vasile, Enrico, Citi, Valentina, Malpeli, Giorgio, Testa, Enrica, Gori, Stefania, Falcone, Alfredo, Amoroso, Domenico, Chella, Antonio, Cappuzzo, Federico, Ardizzoni, Andrea, Scarpa, Aldo, Danesi, Romano
Published in Oncotarget (2016)

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors

by Berardi, Rossana, Torniai, Mariangela, Pusceddu, Sara, Spada, Francesca, Ibrahim, Toni, Brizzi, Maria Pia, Antonuzzo, Lorenzo, Ferolla, Piero, Panzuto, Francesco, Silvestris, Nicola, Partelli, Stefano, Ferretti, Benedetta, Freddari, Federica, Gucciardino, Calogero, Testa, Enrica, Concas, Laura, Murgioni, Sabina, Bongiovanni, Alberto, Zichi, Clizia, Riva, Nada, Rinzivillo, Maria, Brunetti, Oronzo, Giustini, Lucio, Di Costanzo, Francesco, Delle Fave, Gianfranco, Fazio, Nicola, De Braud, Filippo, Falconi, Massimo, Cascinu, Stefano
Published in Cancer Med (2017)